Apriori Bio (Venture)
Funding Details
- Awarder
- Inbox
- Date Award
- July 11, 2022
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $50,000,000
Company Info
- Founders
- Lovisa Afzelius, Ph.D., MBA
- Company Description
- Apriori Bio offers a platform for creating variant-resilient vaccines and provides real-time insights to prepare for future outbreaks.
- Market
- Viral vaccine development
- Location
- Cambridge, MA, USA
- Coinvestors
- Flagship Pioneering